Contingency Management to Promote Smoking Cessation
Key facts
- Who runs it
- University of Kansas Medical Center
- Where
- Kansas City, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 11 Sept 2024
- Ended
- 30 Jan 2026
- Type of study
- Interventional
- Treatments tested
- CounsCM+MedCM (Health Rewards)
- Record updated
- 17 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Smoked in the past 30 days
- Smoke at least 1 cigarette per day when they smoke
- ≥ 18 years old
- Kansas resident
- Speak/read English
- Access to a mobile phone
- Mobile phone receives text messages
- No varenicline contraindications (no acute renal impairment)
- Insurance coverage for varenicline
- Have no significant co-morbidity (i.e., life-threatening illness, communication barriers or altered mental status)
- Cognitively able to participate
- Physically able to participate
- Not pregnant/breastfeeding
Who cannot take part
- Patient on smoking cessation medication within 2 weeks of admission date
- Medically ineligible for varenicline
- Patient already talked to quitline in the past 2 weeks
- Patients participating in other quit smoking program or research study
Where in United States
- University of Kansas Medical CenterKansas City, United States
About the trial
What the trial wants to find out
Many hospitals and outpatient clinics often refer people who smoke to quitlines and provide prescriptions for smoking cessation medications, but patients rarely fully engage in counseling or use their cessation medications. This is a single-arm, open-label pilot study to provide feasibility metrics for a text-based contingency management (CM) intervention to increase engagement in smoking cessation treatment. All participants (N=20) will be referred to a state quitline and will receive a prescription for medication plus 12 weeks of a text-based CM intervention to increase engagement in quitline calls and varenicline utilization. The engagement of participants in quitline counseling will be tracked for 6 weeks and medication utilization for 12 weeks post-enrollment. The investigators will use mixed-methods to collect implementation and acceptability data to inform changes to the text-based contingency management (CM) intervention.
The group in the trial
- MedCM plus CounsCMTreatment being tested
Mobile Contingency Management for counseling attendance and medication intake
Treatment: CounsCM+MedCM (Health Rewards)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 17 June 2026